NCT00220974 Study to Assess if Internet-Based Tailored Advice Could Modify Behaviour to Improve Health Status COMPLETED Phase NA
NCT00220402 Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome Status COMPLETED Phase PHASE3
NCT00220389 Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase Status COMPLETED Phase PHASE2
NCT00220376 Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome Status COMPLETED Phase PHASE3
NCT00220363 A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome Status COMPLETED Phase PHASE3
NCT00219635 Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation Status COMPLETED Phase PHASE2/PHASE3
NCT00219622 A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2
NCT00219583 Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation Status COMPLETED Phase PHASE2/PHASE3
NCT00219557 AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00218205 A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00216866 The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis Status COMPLETED Phase PHASE2
NCT00216086 Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer Status TERMINATED Phase PHASE2
NCT00215670 Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD) Status COMPLETED Phase PHASE2/PHASE3
NCT00215345 A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00215150 Geodon for the Treatment of Refractory Social Anxiety Disorder Status COMPLETED Phase PHASE2
NCT00208260 Intensified Chemotherapy in CRC After Resection of Liver Metastases Status COMPLETED Phase PHASE2/PHASE3